The use of statins in the treatment of systemic scleroderma

Authors

  • O. M. Drapkina Clinic for Propedeutics of Internal Diseases, Gastroenterology and Hepatology. V.Kh. Vasilenko Moscow Medical Academy. I. M. Sechenova
  • M. V. Fadeeva Clinic of propaedeutics of internal medicine, gastroenterology and hepatology, Medical Academy
  • E. V. Zyatenkova Clinic of propaedeutics of internal medicine, gastroenterology and hepatology, Medical Academy

Keywords:

statins, pleiotropic effects, systemic scleroderma

Abstract

Systemic scleroderma is a clinically heterogeneous, systemic disease with microvascular disorders, immune imbalance and enhanced collagen synthesis in tissues. This review focuses on statins' effects on various stages of systemic scleroderma pathogenesis. The presented clinical case illustrates the use of statins in treatment of the systemic scleroderma patient with the anamnesis of myocardial infarction and percutaneous coronary intervention.

Downloads

Download data is not yet available.

Downloads

Published

2016-03-27

How to Cite

Drapkina O. M., Fadeeva M. V., Zyatenkova E. V. The use of statins in the treatment of systemic scleroderma // The Journal of Atherosclerosis and Dyslipidemias. 2016. VOL. № 1 (22). PP. 76–83.

Issue

No. 1 (22) (2016)

Section

Clinical Case